Tela Bio targets at least 8% revenue growth in 2026 while advancing commercial transformation
TELA Bio, Inc. Common Stock · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · Now $0.90
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS